Announcements
Hemogenyx Pharmaceuticals Announces Strategic Investment from Prevail Partners, LLC - 7:15 18/18/2023
Hemogenyx Pharmaceuticals plc (“Hemogenyx Pharmaceuticals” or the “Company”) Hemogenyx Pharmaceuticals Announces Strategic Investment from Prevail Partners, LLC Prevail Partners, LLC to invest in Hemogenyx Pharmaceuticals. Prevail InfoWorks, Inc. to act as Contract Research Organization (CRO) for upcoming Phase I clinical study, expected to commence in 2023. Hemogenyx Pharmaceuticals plc (LSE: HEMO), the biopharmaceutical...
Media Coverage